首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1467656

2024-2032 年重組蛋白市場報告（按產品、應用、最終用戶和地區）

Recombinant Protein Market Report by Product, Application, End User, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年全球重組蛋白市場規模達19.0億美元。

重組蛋白是指由重組DNA編碼的修飾或改變的蛋白。重組DNA分子由質粒組成，其中克隆了目標蛋白的基因。它是透過分子克隆或聚合酶鏈反應（PCR）產生的。一些常見的產品變體包括激酶蛋白、人類胰島素、結構蛋白、黏附分子和受體、免疫反應蛋白等。它被許多生物製藥公司、學術和研究機構、合約研究組織等廣泛採用。

重組蛋白市場趨勢：

幾種慢性疾病盛行率的上升以及對新型治療方案的需求不斷增加，主要推動了全球重組蛋白市場的發展。除此之外，蛋白質工程領域的投資不斷增加以及對蛋白質藥物開發的日益關注正在進一步促進市場成長。此外，許多政府機構正在資助研發活動，以引進蛋白質體學和基因組學的先進技術，這對全球重組蛋白市場產生了重大影響。除此之外，重組蛋白表達技術的出現導致了廣泛用於免疫治療過程的高品質自身抗原的開發。此外，藥物發現領域對重組蛋白精確測量生物標記的需求不斷成長，也為全球市場創造了積極的前景。除此之外，用於生物製藥的最新分子生物學方法的不斷普及，以減少重組蛋白的蛋白水解或防止糖基化的部分或全部損失，預計將在預測期內提振全球重組蛋白市場。

本報告回答的關鍵問題

2023年全球重組蛋白市場規模有多大？
2024-2032年全球重組蛋白市場的預期成長率是多少？
推動全球重組蛋白市場的關鍵因素是什麼？
COVID-19 對全球重組蛋白市場有何影響？
全球重組蛋白市場依應用分類如何？
基於最終用戶的全球重組蛋白市場的細分如何？
全球重組蛋白市場的重點區域有哪些？
全球重組蛋白市場的主要參與者/公司有哪些？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 市場細分：按國家/地區
- 市場預測

第 10 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 13 章：價格分析

第14章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abcam plc
- Amgen Inc.
- Bio-RAD Laboratories Inc.
- Bio-Techne Corporation
- Bps Bioscience Inc.
- Enzo Biochem Inc.
- Genscript Biotech Corporation
- Merck KGaA
- Novo Nordisk A/S
- ProSpec-Tany TechnoGene Ltd
- Sanofi SA
- Thermo Fisher Scientific

簡介目錄圖表

Product Code: SR112024A6079

The global recombinant protein market size reached US$ 1.90 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.58 Billion by 2032, exhibiting a growth rate (CAGR) of 10.1% during 2024-2032.

A recombinant protein refers to a modified or altered protein that is encoded by recombinant DNA. The recombinant DNA molecule consists of a plasmid in which the genes for a target protein are cloned. It is produced either by molecular cloning or polymerase chain reaction (PCR). Some of the common product variants include kinase proteins, human insulin, structural proteins, adhesion molecules and receptors, immune response proteins, etc. Recombinant protein is primarily utilized in the development of novel therapies for chronic and rare diseases. It finds widespread adoption in numerous biopharmaceutical companies, academic and research institutes, contract research organizations, etc.

Recombinant Protein Market Trends:

The elevating prevalence of several chronic diseases along with the increasing demand for novel treatment options is primarily driving the global recombinant protein market. In addition to this, the rising investments in the field of protein engineering and the improving focus on protein-based drug development are further augmenting the market growth. Moreover, numerous government bodies are funding R&D activities for the introduction of advanced techniques in proteomics and genomics, which are significantly impacting the global market for recombinant protein. Besides this, the advent of recombinant protein expression technology has led to the development of high-quality autoantigens that are widely used in immunotherapy procedures. Additionally, the growing requirement for recombinant proteins for accurate measurement of biomarkers in the field of drug discovery is also creating a positive outlook for the global market. Apart from this, the rising penetration of latest molecular biology approaches for biopharming to reduce proteolysis of recombinant proteins or prevent the partial or total loss of glycosylation is expected to bolster the global recombinant protein market over the forecast period.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant protein market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and end user.

Breakup by Product:

Antibodies

Hormones

Growth Factors

Cytokines

Others

Breakup by Application:

Drug Discovery and Development

Academic Research

Biotechnology Research

Biopharmaceutical Production

Others

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies

Biotechnology Companies

Academic and Research Institutes

Contract Research Organization

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Amgen Inc., Bio-RAD Laboratories Inc., Bio-Techne Corporation, Bps Bioscience Inc., Enzo Biochem Inc., Genscript Biotech Corporation, Merck KGaA, Novo Nordisk A/S, ProSpec-Tany TechnoGene Ltd, Sanofi S.A. and Thermo Fisher Scientific.

Key Questions Answered in This Report

1. What was the size of the global recombinant protein market in 2023?
2. What is the expected growth rate of the global recombinant protein market during 2024-2032?
3. What are the key factors driving the global recombinant protein market?
4. What has been the impact of COVID-19 on the global recombinant protein market?
5. What is the breakup of the global recombinant protein market based on application?
6. What is the breakup of the global recombinant protein market based on the end user?
7. What are the key regions in the global recombinant protein market?
8. Who are the key players/companies in the global recombinant protein market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Recombinant Protein Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Antibodies
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Hormones
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Growth Factors
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Cytokines
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Application

7.1 Drug Discovery and Development
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Academic Research
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Biotechnology Research
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Biopharmaceutical Production
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by End User

8.1 Pharmaceutical and Biopharmaceutical Companies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Biotechnology Companies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Academic and Research Institutes
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Contract Research Organization
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 Abcam plc
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Amgen Inc.
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Bio-RAD Laboratories Inc.
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
  - 14.3.3.4 SWOT Analysis
- 14.3.4 Bio-Techne Corporation
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 Financials
- 14.3.5 Bps Bioscience Inc.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
- 14.3.6 Enzo Biochem Inc.
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
  - 14.3.6.3 Financials
  - 14.3.6.4 SWOT Analysis
- 14.3.7 Genscript Biotech Corporation
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
- 14.3.8 Merck KGaA
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
  - 14.3.8.3 Financials
  - 14.3.8.4 SWOT Analysis
- 14.3.9 Novo Nordisk A/S
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
  - 14.3.9.3 Financials
  - 14.3.9.4 SWOT Analysis
- 14.3.10 ProSpec-Tany TechnoGene Ltd
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
- 14.3.11 Sanofi S.A.
  - 14.3.11.1 Company Overview
  - 14.3.11.2 Product Portfolio
  - 14.3.11.3 Financials
  - 14.3.11.4 SWOT Analysis
- 14.3.12 Thermo Fisher Scientific
  - 14.3.12.1 Company Overview
  - 14.3.12.2 Product Portfolio
  - 14.3.12.3 Financials
  - 14.3.12.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Recombinant Protein Market: Major Drivers and Challenges
Figure 2: Global: Recombinant Protein Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Recombinant Protein Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Recombinant Protein Market: Breakup by Product (in %), 2023
Figure 5: Global: Recombinant Protein Market: Breakup by Application (in %), 2023
Figure 6: Global: Recombinant Protein Market: Breakup by End User (in %), 2023
Figure 7: Global: Recombinant Protein Market: Breakup by Region (in %), 2023
Figure 8: Global: Recombinant Protein (Antibodies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Recombinant Protein (Antibodies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Recombinant Protein (Hormones) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Recombinant Protein (Hormones) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Recombinant Protein (Growth Factors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Recombinant Protein (Growth Factors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Recombinant Protein (Cytokines) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Recombinant Protein (Cytokines) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Recombinant Protein (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Recombinant Protein (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Recombinant Protein (Drug Discovery and Development) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Recombinant Protein (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Recombinant Protein (Academic Research) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Recombinant Protein (Academic Research) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Recombinant Protein (Biotechnology Research) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Recombinant Protein (Biotechnology Research) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Recombinant Protein (Biopharmaceutical Production) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Recombinant Protein (Biopharmaceutical Production) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Recombinant Protein (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Recombinant Protein (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Recombinant Protein (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Recombinant Protein (Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Recombinant Protein (Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Recombinant Protein (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Recombinant Protein (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Recombinant Protein (Contract Research Organization) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Recombinant Protein (Contract Research Organization) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Recombinant Protein (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Recombinant Protein (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: North America: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: North America: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: United States: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: United States: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Canada: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Canada: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Asia-Pacific: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Asia-Pacific: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: China: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: China: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Japan: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Japan: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: India: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: India: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: South Korea: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: South Korea: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Australia: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Australia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Indonesia: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Indonesia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Others: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Europe: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Europe: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Germany: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Germany: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: France: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: France: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: United Kingdom: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: United Kingdom: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Italy: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Italy: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Spain: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Spain: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Russia: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Russia: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Latin America: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Latin America: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Brazil: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Brazil: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Mexico: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Mexico: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Others: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Others: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Middle East and Africa: Recombinant Protein Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Middle East and Africa: Recombinant Protein Market: Breakup by Country (in %), 2023
Figure 86: Middle East and Africa: Recombinant Protein Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Global: Recombinant Protein Industry: SWOT Analysis
Figure 88: Global: Recombinant Protein Industry: Value Chain Analysis
Figure 89: Global: Recombinant Protein Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Recombinant Protein Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Recombinant Protein Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Recombinant Protein Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Recombinant Protein Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Recombinant Protein Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Recombinant Protein Market: Competitive Structure
Table 7: Global: Recombinant Protein Market: Key Players

02-2729-4219

+886-2-2729-4219